Vascular Endothelial Growth Factor Blockade Promotes the Transition From Compensatory Cardiac Hypertrophy to Failure in Response to Pressure Overload
暂无分享,去创建一个
[1] H. Drexler,et al. Lack of JunD Promotes Pressure Overload–Induced Apoptosis, Hypertrophic Growth, and Angiogenesis in the Heart , 2005, Circulation.
[2] I. Shiojima,et al. Disruption of coordinated cardiac hypertrophy and angiogenesis contributes to the transition to heart failure. , 2005, The Journal of clinical investigation.
[3] K. Walsh,et al. AMP-Activated Protein Kinase Signaling Stimulates VEGF Expression and Angiogenesis in Skeletal Muscle , 2005, Circulation research.
[4] K. Shyu,et al. Carvedilol prevents cardiac hypertrophy and overexpression of hypoxia-inducible factor-1alpha and vascular endothelial growth factor in pressure-overloaded rat heart. , 2005, Journal of biomedical science.
[5] S. Kihara,et al. Adiponectin-mediated modulation of hypertrophic signals in the heart , 2004, Nature Medicine.
[6] J. Cooke,et al. Adenoviral Gene Transfer With Soluble Vascular Endothelial Growth Factor Receptors Impairs Angiogenesis and Perfusion in a Murine Model of Hindlimb Ischemia , 2004, Circulation.
[7] M. Yacoub,et al. Transplantation of skeletal myoblasts secreting an IL-1 inhibitor modulates adverse remodeling in infarcted murine myocardium , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[8] A. Szczeklik,et al. Comparison of the Effect of Verapamil and Propranolol on Response of Coronary Vasomotion to Cold Pressor Test in Symptomatic Patients with Hypertrophic Cardiomyopathy , 2000, Cardiovascular Drugs and Therapy.
[9] P. Dimitrow,et al. Verapamil Normalizes the Response of Left Ventricular Early Diastolic Filling to Cold Pressor Test in Asymptomatic and Mildly Symptomatic Patients with Hypertrophic Cardiomyopathy , 1997, Cardiovascular Drugs and Therapy.
[10] Shokei Kim,et al. Apoptosis Signal-Regulating Kinase 1 Plays a Pivotal Role in Angiotensin II–Induced Cardiac Hypertrophy and Remodeling , 2003, Circulation research.
[11] E. Abel,et al. Minimally invasive aortic banding in mice: effects of altered cardiomyocyte insulin signaling during pressure overload. , 2003, American journal of physiology. Heart and circulatory physiology.
[12] D. Brutsaert,et al. Cardiac endothelial-myocardial signaling: its role in cardiac growth, contractile performance, and rhythmicity. , 2003, Physiological reviews.
[13] J. Folkman,et al. Adenovirus-mediated delivery of a soluble form of the VEGF receptor Flk1 delays the growth of murine and human pancreatic adenocarcinoma in mice. , 2002, Surgery.
[14] C. Kahn,et al. Akt Signaling Mediates Postnatal Heart Growth in Response to Insulin and Nutritional Status* , 2002, The Journal of Biological Chemistry.
[15] C. Becker,et al. Gene Therapy of Prostate Cancer with the Soluble Vascular Endothelial Growth Factor Receptor Fk1 , 2002, Cancer biology & therapy.
[16] B. Lowell,et al. Adipose tissue mass can be regulated through the vasculature , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[17] D. Mukhopadhyay,et al. Myogenic Akt Signaling Regulates Blood Vessel Recruitment during Myofiber Growth , 2002, Molecular and Cellular Biology.
[18] I. Shiojima,et al. Role of Akt Signaling in Vascular Homeostasis and Angiogenesis , 2002, Circulation research.
[19] Jong-Wan Park,et al. Early Expression of Myocardial HIF-1&agr; in Response to Mechanical Stresses: Regulation by Stretch-Activated Channels and the Phosphatidylinositol 3-Kinase Signaling Pathway , 2002, Circulation research.
[20] J. Rossant,et al. Liver Organogenesis Promoted by Endothelial Cells Prior to Vascular Function , 2001, Science.
[21] Ondine Cleaver,et al. Induction of Pancreatic Differentiation by Signals from Blood Vessels , 2001, Science.
[22] Yusu Gu,et al. A cardiac myocyte vascular endothelial growth factor paracrine pathway is required to maintain cardiac function , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[23] A. Dembińska-kieć,et al. The Time Course of Tumor Necrosis Factor-α, Inducible Nitric Oxide Synthase and Vascular Endothelial Growth Factor Expression in an Experimental Model of Chronic Myocardial Infarction in Rats , 2001, Journal of Vascular Research.
[24] R. D'Amato,et al. Comparative evaluation of the antitumor activity of antiangiogenic proteins delivered by gene transfer , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[25] M. Hendrix,et al. Mechanisms of coronary angiogenesis in response to stretch: role of VEGF and TGF-beta. , 2001, American journal of physiology. Heart and circulatory physiology.
[26] M. Hendrix,et al. Erratum: Mechanisms of coronary angiogenesis on response to stretch: Role of VEGF and TGF-β (American Journal of Physiology - Heart and Circulatory Physiology (February 2001) 280 (H909-H917)) , 2001 .
[27] F. Gaffney,et al. Evidence for angiotensin II type 2 receptor-mediated cardiac myocyte enlargement during in vivo pressure overload. , 2000, The Journal of clinical investigation.
[28] Y. Fujio,et al. Signal Transducer and Activator of Transcription 3 Is Required for Glycoprotein 130-mediated Induction of Vascular Endothelial Growth Factor in Cardiac Myocytes* , 2000, The Journal of Biological Chemistry.
[29] R. Kitsis,et al. Akt promotes survival of cardiomyocytes in vitro and protects against ischemia-reperfusion injury in mouse heart. , 2000, Circulation.
[30] H. Crijns,et al. Regional myocardial blood flow reserve impairment and metabolic changes suggesting myocardial ischemia in patients with idiopathic dilated cardiomyopathy. , 2000, Journal of the American College of Cardiology.
[31] O. Carretero,et al. Echocardiographic assessment of cardiac function in conscious and anesthetized mice. , 1999, American journal of physiology. Heart and circulatory physiology.
[32] S. Pawlowski,et al. Fibroblast growth factor-2 mediates pressure-induced hypertrophic response. , 1999, The Journal of clinical investigation.
[33] N. Ferrara. Molecular and biological properties of vascular endothelial growth factor , 1999, Journal of Molecular Medicine.
[34] Y. Fujio,et al. Akt Mediates Cytoprotection of Endothelial Cells by Vascular Endothelial Growth Factor in an Anchorage-dependent Manner* , 1999, The Journal of Biological Chemistry.
[35] Willem Flameng,et al. Impaired myocardial angiogenesis and ischemic cardiomyopathy in mice lacking the vascular endothelial growth factor isoforms VEGF164 and VEGF188 , 1999, Nature Medicine.
[36] A. Szczeklik,et al. Impaired Response of the Forearm Resistance but not Conductance Vessels to Reactive Hyperemia in Hypertrophic Cardiomyopathy , 1999, Angiology.
[37] M. Shibuya,et al. Interleukin-1βUpregulates Cardiac Expression of Vascular Endothelial Growth Factor and its Receptor KDR/flk-1 via Activation of Protein Tyrosine Kinases , 1999 .
[38] L. Brown,et al. VEGF, flk-1, and flt-1 expression in a rat myocardial infarction model of angiogenesis. , 1996, The American journal of physiology.
[39] P. Anversa,et al. Cellular basis of ventricular remodeling after myocardial infarction in rats. , 1995, Cardioscience.
[40] M. Goldberg,et al. Regulation of vascular endothelial growth factor in cardiac myocytes. , 1995, Circulation research.
[41] F. Marumo,et al. Endothelin ETA receptor antagonist blocks cardiac hypertrophy provoked by hemodynamic overload. , 1994, Circulation.
[42] K E Muffly,et al. Structural Remodeling of Cardiac Myocytes in Patients With Ischemic Cardiomyopathy , 1992, Circulation.
[43] S. Egginton,et al. Angiogenesis in skeletal and cardiac muscle. , 1992, Physiological reviews.
[44] P. Anversa,et al. Myocardial Infarction in Rats: Infarct Size, Myocyte Hypertrophy, and Capillary Growth , 1986, Circulation research.